Leydig cell tumors(LCTs) of testis are uncommon testicular tumors of male gonadal interstitium. Albeit uncommon, they are most basic sex line stromal tumors and contain 1-3 % of every single testicular neoplasm. They generally happen in fourth to 6th decade. In youthful patients, they are for the most part favorable and in grown-ups it very well may be harmful in around 10 % cases. The frequency of Leydig cell tumors is continuously expanding each year which may be credited to expanded utilization of radiological strategies and ensuing early identification of tumors that have not been found in authentic arrangement. Here we report an instance of favorable Leydig cell tumor testis in a 45-year-old male who gave left sided testicular mass. The patient in this way experienced high inguinal orchidectomy. Histopathological assessment demonstrated amiable unadulterated Leydig cell tumor. Serological examinations uncovered typical testosterone levels, DHEA and androstenedione levels. Immunohistochemical recoloring for inhibin indicated fine granular cytoplasmic inspiration and diffuse positive recoloring for Melan-A which further affirmed the conclusion. The endocrine profile and imaging examinations of such patients may be typical and patients can be absolutely asymptomatic. Anyway intermittent follow up of endocrine profile and imaging must be done the same number of cases have been accounted for which had disturbed endocrine levels and presence of atypical side effects significantly following quite a while of one-sided orchidectomy. Our case likewise presents with ordinary hormonal levels, from this time forward for a superior visualization we should recognize favorable LCTs and do long haul development.
Awards 2021: Cancer Science & Therapy
Awards 2021: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Research Article: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Editorial: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Scientific Tracks Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
ScientificTracks: Cancer Science & Therapy
ScientificTracks: Cancer Science & Therapy
Cancer Science & Therapy received 5332 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 